|
Index of reports
> All cases (8)
> Cases with Visual Field Defect (2)
Below is the selection of adverse event reports related to Alphagan P (Brimonidine Ophthalmic) that includes all cases where reactions include visual field defect.
Adverse event in male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a individual with unspecified qualification from United States on 2007-10-09
Patient: male, weighing 93.0 kg (204.6 pounds)
Adverse reactions / side effects: Astigmatism, Drug Ineffective, Coma, Photopsia, Diplopia, Vitreous Floaters, Photophobia, Glare, Eye Operation Complication, Depression, Crying, Cataract, Mydriasis, Visual Field Defect, Partner Stress, Social Problem, Loss of Employment, Activities of Daily Living Impaired, Mental Disorder, DRY Eye
Suspect drug(s):
Pilocarpine
Dosage: 4 drops daily occlusive dressing
Indication: Pupillary Disorder
Start date: 2004-10-15
End date: 2007-07-03
Alphagan P
Dosage: 4 drops daily occlusive dressing
Indication: Pupillary Disorder
Start date: 2004-10-15
End date: 2007-10-06
Adverse event in 86 year old male receiving Alphagan P (Brimonidine Ophthalmic)
Reported by a physician from United States on 2007-04-26
Patient: 86 year old male, weighing 68.3 kg (150.3 pounds)
Adverse reactions / side effects: Pupillary Reflex Impaired, Eye Irritation, Visual Field Defect, Corneal Scar, Documented Hypersensitivity TO Administered Drug, Drug Hypersensitivity, Ocular Hyperaemia
Suspect drug(s):
Alphagan P
Dosage: 1 drop ou q 8 hours
Indication: Glaucoma
Start date: 2006-09-22
End date: 2006-12-12
Alphagan
Dosage: 1 drop ou q 12 hours
Indication: Glaucoma
Start date: 2001-09-03
End date: 2002-09-12
Other drugs received by patient: Cosopt; Travatan; Aspirin; Terazosin HCL; Simvastatin; Levalbuterol Tart; Ipratropium BR; Flunisolide; Colchicine; Brimonidine Tartrate; Meclizine
|
